Research Topics
| Andrew R McCulloughSummaryAffiliation: New York University School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trialAndrew R McCullough
New York University Medical Center Urology, New York, NY, USA
J Sex Med 5:476-84. 2008..After bilateral nerve-sparing radical retropubic prostatectomy (BNSRRP), nocturnal and sexually mediated erections may help to preserve normal erectile function (EF)...
Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrateAndrew R McCullough
Department of Urology, New York University School of Medicine, New York, New York, USA
J Urol 183:2451-6. 2010..To our knowledge we report the first large, randomized, prospective penile rehabilitation clinical trial to compare the effectiveness of nightly intraurethral alprostadil vs sildenafil citrate after nerve sparing prostatectomy...
Phosphodiesterase-5 inhibitors: clinical market and basic science comparative studiesAndrew McCullough
New York University School of Medicine, 150 East 32nd Street, Second Floor, New York, NY 10016, USA
Curr Urol Rep 5:451-9. 2004....
Penile change following radical prostatectomy: size, smooth muscle atrophy, and curveAndrew McCullough
Department of Urology, New York University School of Medicine, New York, NY 10016, USA
Curr Urol Rep 9:492-9. 2008..The mechanism has not yet been elucidated. This article reviews in detail the existing studies on loss of penile size after prostatectomy and possible etiologic mechanisms...
Sildenafil citrate efficacy 8 h postdose in men with mild to moderate erectile dysfunctionA R McCullough
Sexual Health Fertility and Microsurgery, New York University School of Medicine, New York, NY 10016, USA
Int J Impot Res 20:388-95. 2008..Thus, responsiveness to 100 mg sildenafil may persist for 8 h postdose in men with mild to moderate ED...
A prospective study of the beneficial effects of dose optimization and customized instructions on patient satisfaction with sildenafil citrate (Viagra) for erectile dysfunctionAndrew R McCullough
Department of Urology, New York University School of Medicine, New York, New York 10016, USA
Urology 68:38-46. 2006..These results were enhanced with dose optimization, individual patient counseling, and customized instructions...
Randomized, double-blind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: efficacy at 8 and 12 hours postdoseAndrew R McCullough
New York University School of Medicine, New York, New York 10016, USA
Urology 71:686-92. 2008..To clarify the period of responsiveness to sildenafil...
Rehabilitation of erectile function following radical prostatectomyAndrew R McCullough
Department of Urology, New York University School of Medicine, New York, NY 10016, USA
Asian J Androl 10:61-74. 2008..This article reviews the epidemiology, experimental pathophysiological models, rationale for penile rehabilitation, and currently published rehabilitation strategies...
Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunctionAndrew R McCullough
Department of Urology, New York University Medical Center, New York, New York 10016, USA
Urology 60:28-38. 2002..Using these recommended measures, most men with ED, including those whose treatment was previously unsuccessful, can be treated successfully with sildenafil...
Penile oxygen saturation in the flaccid and erect penis in men with and without erectile dysfunctionPriya Padmanabhan
New York University School of Medicine, Department of Urology, 150 East 32 Street, New York, NY 10012, USA
J Androl 28:223-8. 2007..This may help further elucidate the relationship between corporal hypoxia and the development and progression of ED and possibly its treatment and prevention...
An update on the PDE-5 inhibitors (PDE-5i)Andrew R McCullough
New York University School of Medicine, New York, New York 10016, USA
J Androl 24:S52-8. 2003
A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunctionIrwin Goldstein
Sexual Medicine, Alvarado Hospital, San Diego, CA 92120, USA
J Sex Med 9:1122-33. 2012..Phosphodiesterase type 5 (PDE5) inhibitors have become standard treatment for erectile dysfunction (ED)...
A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertionAndrew R McCullough
Albany Medical College, Albany, NY 12208, USA
J Sex Med 9:594-601. 2012..Six academic institutions collaborated and combined their databases to more fully characterize serum testosterone levels after the pellet implantations...
Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's diseaseWayne J G Hellstrom
Department of Urology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA
J Urol 176:394-8. 2006..We investigated the efficacy and safety of intralesional interferon alpha-2b for the treatment of Peyronie's disease...
Erectile function rehabilitation in the radical prostatectomy patientJohn P Mulhall
Memorial Sloan Kettering Cancer Center, Sexual and Reproductive Medicine, New York, NY, USA
J Sex Med 7:1687-98. 2010..Erectile function preservation (rehabilitation) has gained significant traction worldwide despite the absence of definitive evidence in its favor...
Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a phase I trialArnold Melman
Department of Urology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Isr Med Assoc J 9:143-6. 2007..A phase I clinical trial that used hMaxi-K has been completed and a similar trial to assess safety of the transfer for overactive bladder is about to begin...
hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trialArnold Melman
Department of Urology, Albert Einstein College of Medicine Montefiore Medical Center, Bronx, NY 10461, USA
Hum Gene Ther 17:1165-76. 2006....
The first human trial for gene transfer therapy for the treatment of erectile dysfunction: preliminary resultsArnold Melman
Department of Urology, Albert Einstein College of Medicine, Room 744, Forchheimer, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Eur Urol 48:314-8. 2005..CONCLUSION: Preliminary results indicate that, in a single dose escalation study, ion channel gene transfer with hMaxi-K can be administered safely to men with ED without adverse events...
